OncoKB™ (@oncokb) 's Twitter Profile
OncoKB™

@oncokb

MSK's precision oncology knowledge base w/ information about the effects & clinical implications of individual cancer gene alterations. Partially FDA-recognized

ID: 735554548677414913

linkhttps://www.oncokb.org calendar_today25-05-2016 19:34:05

152 Tweet

1,1K Takipçi

0 Takip Edilen

OncoKB™ (@oncokb) 's Twitter Profile Photo
OncoKB™
@oncokb

a year ago

New OncoKB data release v4.18: KRAS G12C promoted to L1 in CRC w/ adagrasib + cetuximab. Osimertinib + chemo added as L1 in EGFR L858R & ex19del in NSCLC. Repotrectinib promoted to L1 in NTRK fusions in solid tumors. 5 new genes. And much more!

New OncoKB data release v4.18: KRAS G12C promoted to L1 in CRC w/ adagrasib + cetuximab. Osimertinib + chemo added as L1 in EGFR L858R & ex19del in NSCLC. Repotrectinib promoted to L1 in NTRK fusions in solid tumors. 5 new genes. And much more!